Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136,591 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma.
Zhang Q, Zu C, Jing R, Feng Y, Zhang Y, Zhang M, Lv Y, Cui J, Zhou L, Meng Y, Wang L, Cen Z, Chang AH, Hu Y, Huang H. Zhang Q, et al. Among authors: wang l. Front Immunol. 2023 May 4;14:1125357. doi: 10.3389/fimmu.2023.1125357. eCollection 2023. Front Immunol. 2023. PMID: 37215107 Free PMC article.
CAR-T cells: the Chinese experience.
Wang L, Tan Su Yin E, Zhao H, Ni F, Hu Y, Huang H. Wang L, et al. Expert Opin Biol Ther. 2020 Nov;20(11):1293-1308. doi: 10.1080/14712598.2020.1790521. Epub 2020 Jul 14. Expert Opin Biol Ther. 2020. PMID: 32605454 Review.
Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma.
Hong R, Tan Su Yin E, Wang L, Zhao X, Zhou L, Wang G, Zhang M, Zhao H, Wei G, Wang Y, Wu W, Zhang Y, Ni F, Hu Y, Huang H, Zhao K. Hong R, et al. Among authors: wang g, wang l, wang y. Front Oncol. 2021 Aug 4;11:713577. doi: 10.3389/fonc.2021.713577. eCollection 2021. Front Oncol. 2021. PMID: 34422666 Free PMC article.
Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy.
Zhang M, Zhou L, Zhao H, Zhang Y, Wei G, Hong R, Wu W, Xu H, Wang L, Ni F, Cui J, Peng S, Huang CH, Chang AH, Hu Y, Huang H. Zhang M, et al. Among authors: wang l. Clin Cancer Res. 2021 Dec 1;27(23):6384-6392. doi: 10.1158/1078-0432.CCR-21-2031. Epub 2021 Sep 21. Clin Cancer Res. 2021. PMID: 34548316 Free PMC article.
COVID-19 in Hematologic Malignancies: Big Challenges.
Hu Y, Wang L, Cui Q, Su Yin ET, Wu H, Nagler A, Huang H. Hu Y, et al. Among authors: wang l. Clin Hematol Int. 2020 Oct 7;2(4):173-175. doi: 10.2991/chi.k.200919.001. eCollection 2020 Dec. Clin Hematol Int. 2020. PMID: 34595459 Free PMC article. No abstract available.
136,591 results
You have reached the last available page of results. Please see the User Guide for more information.